1. Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W (2003) Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 28: 27-36
  2. Adam O, Schattenkirchner M (1988) Untersuchungen zur transsynovialen Kinetik der Eicosapentaensaure und ihren Einfluss auf den Prostaglandin E2- und Tromboxangehalt in der Synovia. Klin Wochenschr 66 (Suppl XIII):117
  3. Adam O, Wolfram G, Zollner N (1986) Effects of alpha-linolenic acid in human diet on linoleic acid metabolism and prostaglandin biosynthesis. J. Lip Res 27: 421-426
  4. Andersson J, Bjork L, Dinarello CA, Towbin H, Andersson U (1992) Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur. J. Immunol 22: 2617-2623
  5. Arthritis Rheum, 1996 : 39: 648-56
  6. Ann Intern Med. 1996: 125: 353-9: Arthritis Rheum, 1999; 42: 854-60
  7. Arthritis Rheum, 1991: 34: 1205-6: Ann Rheum Dis, 1997: 56: 649-55
  8. Am J. Med. 1987; 83 (Suppl 5A): 1-4 JAMA, 1999; 282: 1929-33
  9. Barclay TS, Tsourounus C, Mc Cart GM, Glucosamine. Ann Pharmacother 1998; 32:574-9
  10. Belch JJF (1989) Eicosanoids and rheumatology: inflammatory and vascular aspects. Prostagl Leukotr Ess Fatty Acids 36: 219-234
  11. Berger M, O'Shea J. Cross AS Folks TM Chrused TM Brown EJ, Frank MM (1984) Human neutrophils increase expression of C3bi as well as C3b recptors upon activation. J. Clin Invest 74: 1566-1571
  12. Berger M, Wetzler EM, Wallis RS (1988) Tumor necrosis factor is the major monocyite that increases complement receptor expression on mature human neutrophils. Blood 71: 151-158
  13. Bijlasma JWJ, Romijnders ACM. Artrose In: Bijlsma JWJ, Voorn ThB. Praktische huisartsgeneeskunde, reumatologie Houten: Bohn Stafleu van Loghum 2000.p.194-205
  14. Bourgeois P, Charles G, Dehais J. Delcambre B, Kuntz JL, Rozenberg S. Efficacy and tolerability of chondroitin sulphate 1200 mg/day vs chondroitin sulphate 3 x 400 mg day vs placebo. Osteoarthritis Cartilage 1998;6Suppl A25:25-30
  15. Brandt KD. Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis? Rheum Dis Clin North Am 1993; 19:24-44
  16. Conrozier T. Les traitements anti-arthrosiques: efficacité et tolerance des chondroitines sulfates (CS 4&6). Presse Med 1998:27:1862-5
  17. Darlington LG, Ramsey NW (1993) Review of dietary therapy for rheumatoid arthritis Brit J Rheumatol 32: 507-512
  18. Deal CL, Moskowitz RW, Nutraceuticals as therapeutic agents in osteoarthritis: the role of glucosamine, chondroitin sulphate and collagen hydrolysate. Rheum Dis Clin North Am 1999;25:379-95
  19. Gouze JN, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J, et al. Interleukin-1r down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosythesis. Influence of glucosamine on interleukin-Ir-mediated, effects in rat chondrocytes Arthritis Rheum 2001; 44: 351-360.
  20. Griffin MR, Brandt KD, Liang MH, Pincus T, Ray WA, Practical management of osteoarthritis integration of pharmacologic and  nonpharmacologic measures. Arch Fam Med 1995; 4:1049-55
  21. Houpt JB, McMillan R, Wein C, Paget-Dellio SD Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999;26:2423-30
  22. Largo R, Alvarez-Soria MA, Diez-OrtegoI, Calvo E, Sanchez-Pernante O, Egido J et al, Glucosamine inhibits IL-i beta-induced Nfkappa B activation in human osteoarthritic chondrocytes, Osteoarthritis Cartilage, 11: 290-298
  23. Mc Alindon TE, La Valley MP, Gullin JP Felson DT Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75
  24. McKenzie, L.S., Horsburgh, B.A., Ghosh, P. en Taylor, T.K.F., Osteoarthrosis:  Uncertain Rationale for Anti-inflammatory Drug Therapy, Lancet 1: 908-909, 1976.
  25. Palmoski, J.J. en Brandt, K.D., Effects of Some Non-Steroidal Anti inflammatory Drugs Proteoglycan Metabolism and Organization in Canine Articular Cartilage. Arthritis and Reumatism 23:1010-1020, 1980
  26. Pavelka K, Bucsi L, Manopulo R. Double blind, dose effect study of oral Chondroitin 4 &^6 1200 mg against placebo in the treatment of femoro tibial osteoarthritis. Eular Rheumatol Litera 1998;27 Suppl 2:63
  27. Pujalte JM Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin 1980;7:110-4
  28. Reginster JY, Deroisy R, Rovati LC, et al. Long term effects of glucosamine sulphate on osteoarthritis progression: a randomized placebo controlled clinical trial. Lancet 2001; 357:251-6
  29. Reichelt A, Forster KK, Fischer M, Rovati LCLC, Setnikar I Efficancy and safety of intramuscular glucosamine sulphate in osteoarthritis of the knee. A randomised, placebo-controlled, double blind study Arzneimittelforschung 1994:44-75-80.
  30. Vajaradul Y. Double blind clinical evaluation of intra articular glucosamine in outpatients with gonarthrosis. Clin Ther 1981:3:336-43
  31. Vidal y Plana, R.R. Bizzardi, D. En Rovati, A.L., Articular Cartilage Pharmacology : In Vitro Studies on Glucosamine and Non-steroidal Anti inflammatory Drugs. Pharmacological Research Communications 10(6):557-569, 1978.
  32. Vidal y Plana, R.R. Bizzardi, D. En Rovati, A.L., Articular Cartilage Pharmacology : In Vitro Studies on Glucosamine and Non-steroidal Anti inflammatory Drugs. Pharmacological Research Communications 10(6):557-569, 1978.
  33. Towheed TE, Anastassiades TP, Glucosamine therapy for osteoarthritis, J. Rheumatol 1999; 26: 2294-2297.
  34. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY, Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta analysis. Arch Intern Med 2003; 163: 1514-1522.
  35. Cibere J, Kopec JA, Thorne A, Singer J, Canvin J, Robinson DB, et al. Randomized, double-blind, placebo controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 2004; 51: 738-745.
  36. Mc Alindon T, Formica M, La Valley M, Lehmer M, Kabbara. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am I Med 2004; 117:643-649.
  37. Morreale P, Manopulo R, Galati M, Boccanera L, Saponatie J, Bocchi L, Comparison of the anti-inflammatory efficacy of chondroitin sulphate and diclofenac sodium in patients with knee osteoarthritis. J. Rheumatol 1996;23: 1385-1391.
  38. Michel B, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, et al. Chondroitins 4 en 6 sulfate in osteoarthritis of the knee. Arthritis Rheum 2005; 52:  779-786.
  39. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma J.W., Dieppe P, et al. EULAR recommendations 2003; an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT), Ann Rheum Dis 2003; 62: 1145-1155.
  40. Reginster Jy, Deroisy R, Rovati LC, Lee RJ, Lejeune E, Bruyere O, et al Longterm effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled, clinical trial, Lancet 2001; 357; 251-256.
  41. Zhang X, Rimpilainen M, Simelyte E, Toivanen P. Enzyme degradation and proinflammatory activity in arthritogenic and nonarthtitogenic Eubacterium aerofaciens cell walls. Infect Immun. 2001 Dec; 69(12):7277-84
  42. Simelyte E, Rimpilainen M, Zhang X, Toivanen P. Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis. Ann Rheum Dis. 2003 Oct; 62(10):976-82
  43. Arman MI Arthritis in lambliasis intestinals (giardiasis) in the adult. Z Rheumatol 1991 Jul-Aug; 50(4):216-8 Ann Rheum Dis 1990 Mar; 49(3):192-3
  44. Trollmo C, Sollerman C, Carlsten H, Tarkowski A. The gut as an inductive site for synovial ad extra-articular immune responses in rheumatoid arthritis. Ann Rheum Dis. 1994 Jun;53(6): 377-82
  45. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J. Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappa. Nat Med.2005 Feb; 11(2):183-90. Epub 2005 Jan 30.
  46. Davis MA, Ettinger WH, Neuhaus JM. Obesity and osteoarthritis of the knee: evidence from the National Health and Nutrition Examination Survey (NHANES 1). Semin Arthritis Rheum. 1990 Dec; 20 (3suppl 1):34-41.
  47. Scand J Rheumatol, 2001; 30: 1-10.
  48. Ann Allergy, 1949; 7:200
  49. Lancet, 1986: I 236-8